Summary: <br> <a href="https://twitter.com/intent/tweet?url=http%3A%2F%2Fwww.talkingbiotechpodcast.com%2F315-integrated-molecular-strategies-in-combating-disease%2F&via=talkingbiotech" class="twitter-share-button" data-size="large">Tweet</a><br> <a href="https://i0.wp.com/www.talkingbiotechpodcast.com/wp-content/uploads/2021/10/315-ostertag-cover.jpg"></a><br> New strategies in gene therapy are integrating multiple modern techniques to take on contemporary challenging diseases, such as solid-tumor cancers. Dr. Eric Ostertag of Poseida Therapeutics describes their transposon-based gene therapies that deliver useful gene replacements through biodegradable, tissue-targeted nanoparticles. This contrasts against the older gene therapy technologies that relied on viral delivery. In addition, Poseida offers new approaches in CAR-T cell therapies, genetic adjustment of native immune cells to target cancers. These One-time treatments appear to be promising in treating a variety of cancers using innovative strategies.<br> <a href="https://poseida.com/">Posieda Therapeutics Website </a><br>
